Bengaluru: MedGenome has unveiled its #CarefortheRare campaign ahead of Rare Disease Day. The campaign highlights the critical role of genomic testing in the early detection and management of rare diseases, aiming to raise awareness about the profound impact of undiagnosed inherited diseases and the families caring for loved ones affected by such conditions.
MedGenome’s campaign is centered around a poignant documentary showcasing the emotional journey of a mother whose child was diagnosed with mitochondrial disease at just six months old. In the video, the mother shares the heart-wrenching story of her seemingly healthy baby who was later diagnosed with a rare condition that profoundly altered the course of their lives. The documentary also features insights from the clinician overseeing the child’s care, emphasizing how the advent of genetic testing has revolutionized rare disease diagnosis and management, providing much-needed closure and solutions for families who once faced uncertainty.
Dr. Ann Agnes Mathew, Consultant Pediatric Neurologist and Neuromuscular Specialist, who played a key role in this case, remarked, “Mitochondrial disease was once considered a death sentence. This condition causes mitochondria in cells to lose function, leading to decreased energy production, resulting in muscle weakness, neurological issues, developmental delays, and organ dysfunction. The severity of the disease varies from person to person and can worsen over time. Without genetic testing there was no way to identify this disease and traditionally, there was no cure, with treatment focused on managing symptoms and supporting the affected areas of the body. However, recent research has shown that a ketogenic diet may offer significant benefits in managing the disease. While following this diet is a long and challenging process, the results have been promising. I commend the family and child who have committed to this strict regimen and have seen encouraging improvements.”
Dr. Vedam Ramprasad, CEO of MedGenome, shared, “Identifying the genetic basis of a disease allows us to take significant steps forward. We can not only provide an accurate diagnosis but also manage the disease more effectively, predict its progression, and prevent its recurrence in other family members. Genomics has completely transformed patient care.”
He continued, “Having a rare disease patient in a family not only affects the patient’s health but also places a significant economic burden on the family. Early detection, carrier screening, and genetic counseling are crucial tools in preventing or managing these diseases more effectively, especially in populations with a high disease burden.”
MedGenome’s #CarefortheRare campaign emphasizes the importance of awareness, early detection, and support for those living with rare diseases. The campaign is a testament to the significant progress made in genomics, including advancements in next-generation sequencing (NGS) and AI-driven healthcare analytics, which are making faster, more comprehensive, and cost-effective diagnostic solutions accessible to a broader population. As a result, individuals are now receiving quicker diagnoses and benefiting from more informed treatment decisions, bringing hope to families affected by rare diseases.
